NCT00210015View on ClinicalTrials.gov

A Study in Subjects With Perennial Allergic Rhinitis

PHASE2CompletedINTERVENTIONAL
Enrollment

630

Participants

Timeline

Start Date

December 31, 2002

Primary Completion Date

April 30, 2003

Study Completion Date

April 30, 2003

Conditions
Perennial Allergic Rhinitis
Interventions
DRUG

INS37217 Nasal Spray

All Listed Sponsors
lead

Merck Sharp & Dohme LLC

INDUSTRY

NCT00210015 - A Study in Subjects With Perennial Allergic Rhinitis | Biotech Hunter | Biotech Hunter